-
UNDERSTANDING CEA CHARACTERISTICS ASSOCIATED WITH COST-SAVING FINDINGS
Mar 18, 2026, 21:38 PM -
ADVANCING EQUITY IN PROSTATE CANCER RESEARCH: STRATEGY AND OUTCOMES FROM A PROSPECTIVE ENROLLMENT INITIATIVE
Mar 18, 2026, 21:38 PM -
REAL-WORLD ROS1 TESTING IN FIRST-LINE NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
FDA APPROVALS OF SPECIALTY DRUGS, 2000-2024
Mar 18, 2026, 21:38 PM -
DEVELOPMENT AND VALIDATION OF AN ALGORITHM TO IDENTIFY ASPIRIN USE FROM ELECTRONIC MEDICAL RECORDS AND CLAIMS DATA
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN ASSOCIATED WITH SJÖGREN’S DISEASE (SJD): A SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM -
REAL-WORLD ADHERENCE TO GLP-1RA AND DUAL GIP-GLP-1RA AMONG COMMERCIALLY INSURED US PATIENTS WITH TYPE 2 DIABETES AND OBESITY
Mar 18, 2026, 21:38 PM -
A POPULATION-BASED EPIDEMIOLOGICAL ANALYSIS WITH PROJECTIONS OF FETAL AND NEONATAL TRANSIENT METABOLIC DISORDERS IN HUNGARY
Mar 18, 2026, 21:38 PM -
US MEDICINE PRICING POLICY CHANGES: IMPACT ON THE FULL BIOPHARMACEUTICAL INVESTMENT ECOSYSTEM
Mar 18, 2026, 21:38 PM -
PROFESSIONAL QUALITY OF LIFE, BURNOUT AND SOCIAL SUPPORT AMONG HUNGARIAN PALLIATIVE NURSES
Mar 18, 2026, 21:38 PM -
REPOSITIONING HEOR AS A RISK MITIGATION TOOL FOR HEALTHCARE INVESTMENT DECISION-MAKING: GOOD VALUE FOR MONEY?
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH TIME TO TREATMENT INITIATION FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS IN AN ACADEMIC MEDICAL SYSTEM
Mar 18, 2026, 21:38 PM -
COMPARATIVEEFFICACYANDSAFETYOF LONG-ACTING ANTIRETROVIRAL THERAPY IN HIV-1 MANAGEMENT: A NETWORK META-ANALYSIS
Mar 18, 2026, 21:38 PM -
THE DYNAMICS OF EXACERBATION-RELATED HEALTH-STATE TRANSITIONS IN UNCONTROLLED ASTHMA: A MARKOV-BASED MULTI-CRITERIA ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF PHARMACIST-LED VIDEO TELEHEALTH MEDICATION THERAPY MANAGEMENT IN ADOLESCENTS AND YOUNG ADULTS WITH ASTHMA: A RANDOMIZED CONTROLLED TRIAL
Mar 18, 2026, 21:38 PM -
SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT OF FINERENONE IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) AND HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION (HFMREF):IMPLICATIONS FOR U.S. HEALTHCARE DECISION-MAKERS
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF CLOSED-SYSTEM AND OPEN-SYSTEM INFUSION OF HUMAN SERUM ALBUMIN IN ICU PATIENTS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF ROBOTIC-ASSISTED VERSUS LAPAROSCOPIC SURGERY FOR MID-LOW RECTAL CANCER: EVIDENCE FROM A MULTICENTER RANDOMIZED TRIAL IN CHINA
Mar 18, 2026, 21:38 PM -
ARTIFICIAL INTELLIGENCE-DRIVEN CLINICAL DRUG REPORT GENERATION
Mar 18, 2026, 21:38 PM
